We have continued adding new drugs to the Cancer Therapies class of comedications and a further six drugs are now included:
- Alectinib
- Asciminib
- Atezolizumab
- Avapritinib
- Axitinib
- Cemiplimab
(Details of the first four new comedications can be found here.)
In addition, abrocitinib (a JAK inhibitor used for the treatment of atopic dermatitis) has been added to the Immunosuppressant class of comedications.
